Security key
57055L107
Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR)
CUSIP: 57055L107
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, Par Value $0.001
- Total 13F shares
- 73,700
- Total 13F value
- $229,000
- Share change
- 0
- SEC-reported price per share
- $3.11
- Number of holders
- 1
- Shares outstanding
- 12,939,536
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1
Top holders
1
MRKR full security history
Ownership snapshot
Full 13F holder table
Marker Therapeutics, Inc. SEC filings
Marker Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of MRKR - Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
New Enterprise Associates...
Disclosed value leader
New Enterprise Associates...
Comparable rows
0/15
Latest evidence
23 Dec 2024
3/4/5
13F
Highest disclosed value: $5,202,170
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
New Enterprise Associates 16, L.P. has the largest disclosed position value at $5.2M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens New Enterprise Associates 16, L.P.'s linked filing trail.
Disclosed position value
Top 5
New Enterprise Associates 16, L.P.
$5.2M
NEA Management Company, LLC
$3.02M
Aisling Capital Management LP
$886.3K
VANGUARD GROUP INC
$685.6K
Peter L. Hoang
$234.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$5,202,170
1,625,678 shares
|
— | 23 Dec 2024 |
| NEA Management Company, LLC |
13F
Company
|
—
denominator unverified
|
$3,021,427
1,071,428 shares
|
— | 30 Sep 2024 |
| Aisling Capital Management LP |
13F
Company
|
—
denominator unverified
|
$886,286
314,286 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$685,604
243,122 shares
|
— | 30 Sep 2024 |
| Peter L. Hoang |
3/4/5
President and CEO, Director
|
—
denominator unverified
|
$234,297
483,286 shares
|
— | 24 Mar 2022 |
| AR ASSET MANAGEMENT INC |
13F
Company
|
—
denominator unverified
|
$208,000
73,700 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
73,700
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
1
Q4 2024 holders
1
Holder diff
0
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|